Research & Development

Our Research & Development department gives our business its competitive edge, both in improving the quality of existing GSK vaccines and in generating ideas and concepts for innovative new products.

Our R&D process seeks to push boundaries while taking a realistic approach to technology, partnerships, and using available resources wisely. We also emphasise the value of teamwork and responsibility in developing new vaccines.

The department undertakes research in four disease areas: Viral & Allergy Vaccines, Bacterial Vaccines, Emerging Diseases & HIV, and Cancer Vaccines. A substantial proportion of our R&D programme is oriented towards controlling diseases that hit the poorest countries hardest.

Clinical studies are currently being carried out to assess the efficacy of vaccines against TB, HIV/AIDS, and malaria, while vaccines for dengue and other developing world diseases are at an earlier stage of development.

For this department we are looking for scientists with a doctorate or post-doctoral qualification in life sciences, and ideally experience in virology, immunology or molecular biology.

You should have a keen interest in staying abreast of the latest developments in global healthcare. We are also interested in receiving applications from people with the drive, motivation and leadership skills to manage laboratory-based teams.